Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer
Hiroshi Kawaguchi(New Tokyo Hospital), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences)
Cited by 25
Related Papers
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
|Oncology Reports|2017|115
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer
|Journal of Ovarian Research|2014|108
Decorin induced by progesterone plays a crucial role in suppressing endometriosis
|Journal of Endocrinology|2014|37